Xulin Liu
Papers
1
Total Citations
2
H-Index
1
About
Dr. Xulin Liu is a leading surgical oncologist whose research focuses on optimizing minimally invasive approaches for hepatocellular carcinoma (HCC) treatment, particularly through comparative effectiveness studies of robotic-assisted, laparoscopic, and open liver resection. Dr. Liu’s most notable contribution is the landmark nationwide cohort study examining clinical and economic outcomes for BCLC 0/A HCC patients undergoing hepatectomy. This work, already garnering 2 citations shortly after its 2025 publication, provides critical evidence to resolve ongoing debates about the optimal surgical technique by systematically comparing safety profiles, oncologic outcomes, and healthcare costs across all three approaches. By leveraging real-world national data, Dr. Liu’s research directly informs surgical decision-making and healthcare policy, helping to define which patients benefit most from robotic or laparoscopic techniques versus traditional open surgery. This study represents a significant step toward personalized surgical care in HCC management, addressing both clinical efficacy and economic sustainability. Dr. Liu’s work continues to shape the evolving landscape of hepatobiliary surgery, with implications for improving patient outcomes and resource allocation in cancer care.
Research Focus
Key Achievements
Top Papers
- 1